Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
AIM ImmunoTech Inc. (HEB) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 PREC14A Form PREC14A - Preliminary proxy statements, contested solicitations:
10/10/2023 PREC14A Form PREC14A - Preliminary proxy statements, contested solicitations:
09/29/2023 8-K Quarterly results
08/23/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/23/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "VIA E-MAIL AND FEDEX",
"AIM ImmunoTech Rejects Director Nomination Notice from Activist Group Due to Numerous Material Defects, Omissions and False and Misleading Statements"
08/15/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/07/2023 SC 13D/A Deutsch Todd reports a 3.5% stake in AIM IMMUNOTECH INC.
07/27/2023 SC 13D Deutsch Todd reports a 3.5% stake in AIM IMMUNOTECH INC.
07/10/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
07/03/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
05/12/2023 8-A12B/A Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]
04/19/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
04/19/2023 8-K Quarterly results
03/31/2023 10-K Annual Report for the period ended December 31, 2022
03/30/2023 8-K Quarterly results
03/16/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
03/13/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
03/08/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
03/06/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "AIM ImmunoTech Issues Letter to Stockholders"
02/24/2023 8-K Regulation FD Disclosure  Interactive Data
02/10/2023 8-K Quarterly results
02/10/2023 8-A12B/A Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]
02/06/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
01/17/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
11/14/2022 8-A12B/A Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]
11/14/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/09/2022 8-K Quarterly results
11/03/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
11/01/2022 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
10/31/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
10/27/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
10/26/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
10/24/2022 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy